Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

PPP model can make India one of top 5 global pharma innovation hubs: Study

Government's decision to allow 100% FDI under automatic route in the pharma sector will further enhance R&D activity in India, says a joint study of Assocham and TechSci Research

BS B2B Bureau  |  New Delhi 

To push India into top five pharmaceutical innovation hubs by 2020 and establish global presence by launching 1 out of every 5-10 drugs discovered in India at global level, the government is preparing for multi-billion dollar investment with 50 percent public funding through its public private partnership (PPP) model to enhance innovation capability, reveals the joint study of Assocham and TechSci Research. The government has been very active in boosting growth and investment in Indian pharmaceutical industry. It allows 100 per cent FDI (Foreign Direct Investment) under automatic ...

MONTHLY STAR

Business Standard Digital

Business Standard Digital Monthly Subscription
149.00  
subscribe
Complete access to the premium product
Convenient - Pay as you go
Pay using Master/Visa Credit Card & ICICI VISA Debit Card
Auto renewed (subject to your card issuer's permission)
Cancel any time in the future
Requires personal information

What you get?

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all the content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.

NOTE :

  • The product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the email with the cancellation request to assist@bsmail.in. Include your contact number for speedy action. Requests mailed to any other ID will not be acknowledged or actioned upon.

SMART MONTHLY

Business Standard Digital

Business Standard Digital - 12 Months
1499.00
subscribe
Get 12 months of Business Standard digital access
Single Seamless Sign-up to Business Standard Digital
Convenient - Once a year payment
Pay using an instrument of your choice - Credit/Debit Cards, Net Banking, Payment Wallets accepted
Exclusive Invite to select Business Standard events

What you get

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all content on any device through browser or app.
  • Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.

NOTE :

  • This product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.
First Published: Tue, August 30 2016. 10:51 IST
RECOMMENDED FOR YOU

PPP model can make India one of top 5 global pharma innovation hubs: Study

Government's decision to allow 100% FDI under automatic route in the pharma sector will further enhance R&D activity in India, says a joint study of Assocham and TechSci Research

Government's decision to allow 100% FDI under automatic route in the pharma sector will further enhance R&D activity in India, says a joint study of Assocham and TechSci Research To push India into top five pharmaceutical innovation hubs by 2020 and establish global presence by launching 1 out of every 5-10 drugs discovered in India at global level, the government is preparing for multi-billion dollar investment with 50 percent public funding through its public private partnership (PPP) model to enhance innovation capability, reveals the joint study of Assocham and TechSci Research. The government has been very active in boosting growth and investment in Indian pharmaceutical industry. It allows 100 per cent FDI (Foreign Direct Investment) under automatic ... image
Business Standard
177 22

PPP model can make India one of top 5 global pharma innovation hubs: Study

Government's decision to allow 100% FDI under automatic route in the pharma sector will further enhance R&D activity in India, says a joint study of Assocham and TechSci Research

To push India into top five pharmaceutical innovation hubs by 2020 and establish global presence by launching 1 out of every 5-10 drugs discovered in India at global level, the government is preparing for multi-billion dollar investment with 50 percent public funding through its public private partnership (PPP) model to enhance innovation capability, reveals the joint study of Assocham and TechSci Research. The government has been very active in boosting growth and investment in Indian pharmaceutical industry. It allows 100 per cent FDI (Foreign Direct Investment) under automatic ...

image
Business Standard
177 22